The primary objective of this thorough QT/QTc study was to investigate whether once-daily administration of therapeutic ( @ / @ mg ) and supratherapeutic ( @ / @ mg ) doses of NOMAC/E@ were associated with prolongation of the mean Fridericia-corrected QT ( QTcF ) interval in electrocardiograms at steady-state concentrations of NOMAC/E@ versus placebo .